PH13417A - Thiourea and guanidine derivative having actively as hestamine h2 receptor antagonists and pharmaceuas histamine h2 receptor artagonists and pharmaceutical composition - Google Patents

Thiourea and guanidine derivative having actively as hestamine h2 receptor antagonists and pharmaceuas histamine h2 receptor artagonists and pharmaceutical composition

Info

Publication number
PH13417A
PH13417A PH18667A PH18667A PH13417A PH 13417 A PH13417 A PH 13417A PH 18667 A PH18667 A PH 18667A PH 18667 A PH18667 A PH 18667A PH 13417 A PH13417 A PH 13417A
Authority
PH
Philippines
Prior art keywords
receptor
pharmaceuas
hestamine
artagonists
histamine
Prior art date
Application number
PH18667A
Other languages
English (en)
Inventor
G White
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of PH13417A publication Critical patent/PH13417A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH18667A 1975-07-31 1976-07-09 Thiourea and guanidine derivative having actively as hestamine h2 receptor antagonists and pharmaceuas histamine h2 receptor artagonists and pharmaceutical composition PH13417A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31968/75A GB1565647A (en) 1975-07-31 1975-07-31 Pharmacologically active compounds 4-substituted-imidazole-5-methanols

Publications (1)

Publication Number Publication Date
PH13417A true PH13417A (en) 1980-03-30

Family

ID=10331071

Family Applications (1)

Application Number Title Priority Date Filing Date
PH18667A PH13417A (en) 1975-07-31 1976-07-09 Thiourea and guanidine derivative having actively as hestamine h2 receptor antagonists and pharmaceuas histamine h2 receptor artagonists and pharmaceutical composition

Country Status (28)

Country Link
JP (1) JPS5219663A (xx)
AR (1) AR213100A1 (xx)
AT (1) AT356668B (xx)
AU (1) AU508262B2 (xx)
BE (1) BE843840A (xx)
CA (1) CA1075702A (xx)
CS (1) CS203054B2 (xx)
DD (1) DD125205A5 (xx)
DE (1) DE2634430A1 (xx)
DK (1) DK316376A (xx)
ES (1) ES450309A1 (xx)
FI (1) FI762191A (xx)
FR (1) FR2319341A1 (xx)
GB (1) GB1565647A (xx)
GR (1) GR61114B (xx)
HU (1) HU174068B (xx)
IL (1) IL50006A0 (xx)
LU (1) LU75495A1 (xx)
NL (1) NL7608505A (xx)
NO (1) NO762659L (xx)
OA (1) OA05405A (xx)
PH (1) PH13417A (xx)
PT (1) PT65377B (xx)
RO (1) RO72312B (xx)
SE (1) SE7608478L (xx)
SU (1) SU655310A3 (xx)
ZA (1) ZA763686B (xx)
ZM (1) ZM9676A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
IE47044B1 (en) 1977-04-20 1983-12-14 Ici Ltd Guanidine derivatives
US4112234A (en) 1977-08-22 1978-09-05 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines
USRE31588E (en) * 1977-06-03 1984-05-22 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines
US4233302A (en) 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
EP0008596A1 (fr) * 1978-09-04 1980-03-19 DEVINTER Europe S.A. Société anonyme dite: Procédé de préparation de dérivés du type 4-hydroxyméthyl imidazole à partir d'esters d'acides 4-imidazole carboxyliques correspondants
US4200760A (en) * 1978-09-26 1980-04-29 Bristol-Myers Company Imidazolylalkylthioalkylamino-ethylene derivatives
JPS5914460B2 (ja) * 1978-12-27 1984-04-04 相互薬工株式会社 H↓2受容体「きつ」抗剤シメチジンの製造法
CN103288742A (zh) * 2013-06-04 2013-09-11 四川百利药业有限责任公司 一种高纯度英加韦林原料的制备方法
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA938556A (en) * 1970-06-25 1973-12-18 Smith Kline And French Laboratories Limited Pharmaceutical compositions containing thiourea derivatives

Also Published As

Publication number Publication date
IL50006A0 (en) 1976-09-30
AR213100A1 (es) 1978-12-15
ZA763686B (en) 1977-05-25
NO762659L (xx) 1977-02-01
RO72312B (ro) 1984-03-31
FR2319341A1 (fr) 1977-02-25
GR61114B (en) 1978-09-13
DE2634430A1 (de) 1977-02-10
AU508262B2 (en) 1980-03-13
DK316376A (da) 1977-02-01
BE843840A (fr) 1977-01-06
JPS5219663A (en) 1977-02-15
DD125205A5 (xx) 1977-04-06
ATA552376A (de) 1979-10-15
AU1644776A (en) 1978-02-02
PT65377A (en) 1976-08-01
CS203054B2 (en) 1981-02-27
ES450309A1 (es) 1977-12-01
FI762191A (xx) 1977-02-01
GB1565647A (en) 1980-04-23
RO72312A (ro) 1984-03-15
HU174068B (hu) 1979-10-28
OA05405A (fr) 1981-02-28
NL7608505A (nl) 1977-02-02
AT356668B (de) 1980-05-12
FR2319341B1 (xx) 1979-01-12
SE7608478L (sv) 1977-02-01
SU655310A3 (ru) 1979-03-30
LU75495A1 (xx) 1977-03-03
PT65377B (en) 1978-01-19
ZM9676A1 (en) 1977-07-21
CA1075702A (en) 1980-04-15

Similar Documents

Publication Publication Date Title
IL49528A0 (en) Heterocyclic guanidine and thiourea derivatives and pharmaceutical compositions containing them
NZ195568A (en) Guanidine derivatives and pharmaceutical compositions
CY1131A (en) Pharmaceutical compositions for use in the suppression of gastric reflux
NZ189253A (en) Amine derivatives and pharmaceutical compositions
DE2860474D1 (en) Benzhydryl guanidine derivatives and pharmaceutical compositions
NZ188721A (en) Imidazolidines and pharmaceutical compositions
IL54474A (en) Benzimidazole derivatives,their preparation and anthelmintic compositions containing them
NZ185981A (en) Piperazine derivatives and pharmaceutical compositions
PH13921A (en) Pharmacologically active pyrimidine derivatives and compositions thereof
PH14555A (en) Alkoxypyridyl compound derivatives and pharmaceutical composition useful as histamine h2 antagonists
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
NZ182759A (en) Pyrimidine derivatives and pharmaceutical compositions
PH15980A (en) 2-imidazoline derivatives and pharmaceutical composition
NZ182665A (en) Amine derivatives and pharmaceutical compositions
IT1133631B (it) Derivati di ergoline farmacologicamente attivi
PH13417A (en) Thiourea and guanidine derivative having actively as hestamine h2 receptor antagonists and pharmaceuas histamine h2 receptor artagonists and pharmaceutical composition
NZ184281A (en) Hydantoin derivatives and pharmaceutical compositions
GB2001624B (en) Guanidine derivatives processes for their manufacture and pharmaceutical compositions containing them
NZ184678A (en) Pyrimidine derivatives and pharmaceutical compositions
NZ184755A (en) 2-benzylpyrrolidine derivatives and pharmaceutical compositions
NZ183396A (en) Heterocyclic compounds with histamine h2-antagonist activity, and pharmaceutical compositions
GR60780B (en) Heterocyclic derivatives of guanidine
IL54591A0 (en) Novel benzimidazole derivatives, their manufacture and pharmaceutical compositions containing them
PH13392A (en) Thiourea derivatives and pharmaceutical compositions containing them
JPS5690063A (en) Heterocyclic compound active to histamine receptor* its manufacture and its composition